Vitaspring Biomedical (VSBC) FCF Margin (2017 - 2022)
Vitaspring Biomedical's FCF Margin was -1.88% in fiscal Q1 2023 (quarter ended Apr 30, 2022), down 69.11 percentage points from 67.23% a year earlier and down 1.08 percentage points from the prior quarter.
Powered by 
Analysis
Vitaspring Biomedical (VSBC) FCF Margin (2017 - 2022) Analysis & Trends
For FY2022 (ended Jan 31, 2022), FCF Margin at Vitaspring Biomedical came in at -6.10%, up 10.87 percentage points from FY2021.
- FCF Margin shows a four-year change of -22.43 percentage points (FY2018 to FY2022).
- In earlier fiscal years, FCF Margin was -16.97% in FY2021 (-16.28 pp), -0.69% in FY2020 (+198.65 pp), -199.35% in FY2019 (-215.68 pp) and 16.33% in FY2018.
- Quarterly FCF Margin has moved between -23385.33% (fiscal Q3 2019) and 292.12% (fiscal Q4 2018) over five years.
- The best year-over-year quarter for FCF Margin over five years was fiscal Q2 2020 (a gain of 717.40 percentage points); the worst was fiscal Q3 2019 (a drop of 23369.32 percentage points).
- Per Business Quant data, VSBC's FCF Margin in the three fiscal quarters before Q1 2023 was -0.80% (Q4 2022), 188.40% (Q3 2022) and -70.29% (Q2 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 28.96% |
| 10 | Vitaspring Biomedical | 4.14 Mn | 4.12 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2022 | -1.88% |
| Jan 31, 2022 | -4.99% |
| Oct 31, 2021 | 200.00% |
| Jul 31, 2021 | -70.29% |
| Apr 30, 2021 | 67.23% |
| Jan 31, 2021 | -17.27% |
| Jan 31, 2020 | -3.39% |
| Apr 30, 2019 | 21.01% |
| Jan 31, 2019 | 33.22% |
| Oct 31, 2018 | -23,385.33% |
| Jul 31, 2018 | -728.15% |
| Apr 30, 2018 | -24.32% |
| Jan 31, 2018 | 292.12% |
| Oct 31, 2017 | -16.01% |
| Jul 31, 2017 | -32.00% |
| Apr 30, 2017 | -0.26% |
API Access
Vitaspring Biomedical FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=VSBC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "VSBC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=VSBC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();